Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population

Author： Bergamini M.   Comodo N.   Gasparini R.   Gabutti G.   Fabrizi P.   Severini R.   Ajello F.   Bonanni P.   Castagnari L.   Cocchioni M.   Della Pietra P.   Fragapane E.   Grilli A.   Liberatore S.   Lo Nostro A.   Moiraghi-Ruggenini A.   Pellegrini M.G.   Pozzi T.   Tarsitani G.   Zotti C.   Crovari P.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.3, 1999-02, pp. : 286-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study

By Garca-Corbeira P.   Dal-Re R.   Garca-de-Lomas J.   Aguilar L.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1978-1982

Elsevier

Access to resources Recommend Favorite

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM 197 ) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

By McNeela E.A.   O'Connor D.   Jabbal-Gill I.   Illum L.   Davis S.S.   Pizza M.   Peppoloni S.   Rappuoli R.   Mills K.H.G.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1188-1198

Elsevier

Access to resources Recommend Favorite

Differences in the immunogenicity of native and formalinized cross reacting material (CRM 197 ) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs

By Gupta R.K.   Collier R.J.   Rappuoli R.   Siber G.R.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1341-1343

Elsevier

Access to resources Recommend Favorite

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

By Yasuda Y.   Isaka M.   Taniguchi T.   Zhao Y.   Matano K.   Matsui H.   Morokuma K.   Maeyama J.-i.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2954-2963

Elsevier

Access to resources Recommend Favorite

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa

By Machado A.A.   Baknabua M.   Salaun D.   de Mareuil J.   Krciinak V.   MacGregor R.R.   Chermann J.-C.   Hirsch I.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 321-325

Elsevier

Access to resources Recommend Favorite